Combining CJC-1295 and BPC-157 for Depression Relief CJC-1295 and BPC-157 offers a comprehensive approach to addressing depression by targeting multiple underlying factors: CJC-1295 enhances neuroplasticity, sleep quality, and hormonal balance , while BPC-157 reduces inflammation, repairs neurons, and improves gut health
However, TB-500s larger molecular weight (4,921 Da) means that molar concentrations differ significantly from BPC-157
human bioavailability is unknown Subcutaneous injection Human subcutaneous bioavailability and pharmacokinetics are unknown Factor Convenience Oral capsules No mixing or syringe math Subcutaneous injection Requires reconstitution, sterile supplies, and injection-site planning Factor Evidence limits Oral capsules No controlled human dose, benefit, or safety trial Subcutaneous injection No controlled human dose, benefit, or safety trial Factor Can the amounts be treated as equal
I know one cat that was there, and being collected that night along with Rupie had to be given a sedative
Beyond gastric applications, BPC-157 shows therapeutic potential for lesions throughout the gastrointestinal tract, including esophagus, duodenum, small intestine, colon, liver, and pancreas